Serum Level of PD-1, PD-L1, and PD-L2 as a New Biomarker for Esophageal Cancer

被引：1
|
作者：
Akutsu, Yasunori [1 ]
Murakami, Kentaro [1 ]
Hanari, Naoyuki [1 ]
Kano, Masayuki [1 ]
Uesato, Masaya [1 ]
Ota, Takumi [1 ]
Suito, Hiroshi [1 ]
Matsumoto, Yasunori [1 ]
Takahashi, Masahiko [1 ]
Matsubara, Hisahiro [1 ]
机构：
[1] Chiba Univ, Grad Sch Med, Frontier Surg, Chiba, Japan
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2015年 / 110卷
关键词：
D O I：
10.14309/00000434-201510001-01622
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1622
引用
收藏
页码：S694 / S694
页数：1
相关论文
共 50 条
  • [41] Regulation of Immunity in Clear Cell Renal Carcinoma: Role of PD-1, PD-L1, and PD-L2
    Spirina, Liudmila
    Yurmazov, Zahar
    Usynin, Evgeny
    Kondakova, Irina
    Ladutko, Ekaterine
    Choynzonov, Evgeny
    CURRENT ISSUES IN MOLECULAR BIOLOGY, 2021, 43 (02) : 1072 - 1080
  • [42] TARGETING PD1/PD-L1/PD-L2 SIGNALING IN ENDOMETRIOSIS
    Mamillapalli, Ramanaiah
    Golden, Adriana
    Taylor, Hugh S.
    Gawde, Nimisha
    FERTILITY AND STERILITY, 2023, 120 (04) : E307 - E307
  • [43] Differential expression of PD-L1 and PD-L2, ligands for an inhibitory receptor PD-1, in the cells of lymphohematopoietic tissues
    Ishida, M
    Iwai, Y
    Tanaka, Y
    Okazaki, T
    Freeman, GJ
    Minato, N
    Honjo, T
    IMMUNOLOGY LETTERS, 2002, 84 (01) : 57 - 62
  • [44] Robust Preanalytical Performance of Soluble PD-1, PD-L1 and PD-L2 Assessed by Sensitive ELISAs in Blood
    Krueger, Kimberly
    Mayer, Zsuzsanna
    Kottmaier, Marc
    Gerckens, Miriam
    Boeck, Stefan
    Luppa, Peter
    Holdenrieder, Stefan
    BIOMEDICINES, 2022, 10 (10)
  • [45] PD-L2 generates a signal through the PD-1 co-receptor distinct from that of PD-L1
    Srinivasamani, Anupallavi
    Liu, Qinying
    Curran, Michael
    JOURNAL OF IMMUNOLOGY, 2019, 202 (01):
  • [46] Expression and prognostic value of PD-L1 and PD-L2 in ovarian cancer
    Xue, Chunyan
    Zhu, Dawei
    Chen, Lujun
    Xu, Yun
    Xu, Bin
    Zhang, Dachuan
    Jiang, Jingting
    TRANSLATIONAL CANCER RESEARCH, 2019, 8 (01) : 111 - 119
  • [47] PD-L1 copy number gains: a predictive biomarker for PD-1/PD-L1 blockade therapy?
    Inoue, Yusuke
    Osman, Murat
    Suda, Takafumi
    Sugimura, Haruhiko
    TRANSLATIONAL CANCER RESEARCH, 2016, 5 : S199 - S202
  • [48] PD-1, PD-L1, PD-L2 expression in the chordoma microenvironment (vol 121, pg 251, 2015)
    Mathios, Dimitrios
    Ruzevick, Jacob
    Jackson, Christopher M.
    Xu, Haiying
    Shah, Sagar R.
    Taube, Janis M.
    Burger, Peter C.
    McCarthy, Edward F.
    Quinones-Hinojosa, Alfredo
    Pardoll, Drew M.
    Lim, Michael
    JOURNAL OF NEURO-ONCOLOGY, 2016, 128 (01) : 183 - 183
  • [49] Expression of PD-1, PD-L1, and PD-L2 in posttransplant lymphoproliferative disorder after solid organ transplantation
    Kinch, Amelie
    Sundstrom, Christer
    Baecklund, Eva
    Backlin, Carin
    Molin, Daniel
    Enblad, Gunilla
    LEUKEMIA & LYMPHOMA, 2019, 60 (02) : 376 - 384
  • [50] Association of PD-1, PD-L1 and PD-L2 expression with clinicopathological factors in tongue squamous cell carcinoma
    Tsuchihashi, Kei
    Nakatsugawa, Munehide
    Asanuma, Hiroko
    Miyazaki, Akihiro
    Torigoe, Toshihiko
    CANCER SCIENCE, 2018, 109 : 498 - 498
12345